Following a limited submission
AWMSG advice |
|||
| Status: Recommended | |||
Insulin glargine (Lantus®) 100 units/ml solution for injection is recommended as an option for use within NHS Wales for the treatment of diabetes mellitus in children aged 2 to less than 6 years. |
|||
|
|||
Medicine details |
|||
| Medicine name | insulin glargine (Lantus®) | ||
| Formulation | 100 units/ml solution for injection | ||
| Reference number | 1673 | ||
| Indication | Treatment of diabetes mellitus in children aged 2 to less than 6 years |
||
| Company | Sanofi-Aventis Ltd | ||
| BNF chapter | Endocrine system | ||
| Assessment type | Limited | ||
| Status | Recommended | ||
| Advice number | 0413 | ||
| NMG meeting date | 09/01/2013 | ||
| AWMSG meeting date | 06/02/2013 | ||
| Ratification by Welsh Government | 18/03/2013 | ||
| Date of issue | 22/03/2013 | ||
| Date of last review | 30/09/2016 | ||